Dose Reduction of Baricitinib in Patients with Rheumatoid Arthritis Achieving Sustained Disease Control: Results of a Prospective Study
Ann Rheum Dis. 2019 Feb;78(2):171-178. DOI 10.1136/annrheumdis-2018-213271
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Ann Rheum Dis. 2019 Feb;78(2):171-178. DOI 10.1136/annrheumdis-2018-213271
Ann Rheum Dis. 2018 Jul;77(7):988-995. DOI 10.1136/annrheumdis-2017-212461
Rheumatology 2018;57:1423–1431 DOI: 10.1093/rheumatology/key121
Lancet 2018;391:2513–24
Clin Rheumatol 2018 Aug; 37(8):2043–53
Arthritis Res Ther 2018; 20(1):60 doi: 10.1186/s13075-018-1539-6
Rheumatology (Oxford) 2018; 57(2):309–17
Arthritis Res Ther. 2017 Sep 18;19(1):208
Arthritis Rheumatol. 2017 Sep;69(9):1751-1761. doi: 10.1002/art.40176
J Rheumatol. 2018 Jan;45(1):14-21. doi: 10.3899/jrheum.161161